Details for New Drug Application (NDA): 018045
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 018045 describes EMCYT, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from one supplier. Additional details are available on the EMCYT profile page.
The generic ingredient in EMCYT is estramustine phosphate sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the estramustine phosphate sodium profile page.
The generic ingredient in EMCYT is estramustine phosphate sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the estramustine phosphate sodium profile page.
Summary for 018045
| Tradename: | EMCYT |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | estramustine phosphate sodium |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018045
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 018045
Suppliers and Packaging for NDA: 018045
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| EMCYT | estramustine phosphate sodium | CAPSULE;ORAL | 018045 | NDA | Pharmacia and Upjohn Company LLC | 0013-0132 | 0013-0132-02 | 1 BOTTLE in 1 CARTON (0013-0132-02) / 100 CAPSULE in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 140MG PHOSPHATE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
